Form 8-K - Current report:
SEC Accession No. 0001021771-24-000188
Filing Date
2024-11-06
Accepted
2024-11-06 16:43:22
Documents
17
Period of Report
2024-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT brt8k.htm   iXBRL 8-K 30725
2 AT THE MARKET OFFERING AGREEMENT ex1_1.htm EX-1.1 289320
3 OPINION OF COUNSEL ex5_1.htm EX-5.1 11595
7 image00002.jpg GRAPHIC 7582
8 image00003.jpg GRAPHIC 2957
  Complete submission text file 0001021771-24-000188.txt   550679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA brtx-20241101.xsd EX-101.SCH 3883
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20241101_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20241101_pre.xml EX-101.PRE 16056
19 EXTRACTED XBRL INSTANCE DOCUMENT brt8k_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 241431746
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)